Implementation Guide CH VACD
5.0.0 - trial-use
Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions
<Immunization xmlns="http://hl7.org/fhir">
<id value="TCF01-IMMUN3"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-vacd/StructureDefinition/ch-vacd-immunization"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Immunization TCF01-IMMUN3</b></p><a name="TCF01-IMMUN3"> </a><a name="hcTCF01-IMMUN3"> </a><a name="TCF01-IMMUN3-en-US"> </a><p><b>Author of the content</b>: <a href="Patient-TC-patient.html">Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)</a></p><p><b>CH VACD Extension Immunization Medication Reference</b>: <a href="Medication-TC-IMMUN-MEDIC-HAVRIX1440.html">Medication HAVRIX 1440 Inj Susp</a></p><p><b>identifier</b>: <code>urn:oid:2.16.756.5.30.1.402.1.3.1.1.1</code>/94bdf3b1-0c04-42d3-9901-7e68f124f5ff</p><p><b>status</b>: Completed</p><p><b>vaccineCode</b>: <span title="Codes:{http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-cs 558}">Havrix 1440</span></p><p><b>patient</b>: <a href="Patient-TC-patient.html">Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)</a></p><p><b>occurrence</b>: 2021-05-27</p><p><b>recorded</b>: 2021-05-27 00:00:00+0200</p><p><b>lotNumber</b>: AHAVB946A</p><p><b>route</b>: <span title="Codes:{http://standardterms.edqm.eu 20035000}">Intramuscular use</span></p><h3>Performers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Actor</b></td></tr><tr><td style="display: none">*</td><td><a href="PractitionerRole-TC-HCP1-ORG1-ROLE-performer.html">PractitionerRole</a></td></tr></table><p><b>note</b>: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)</p><h3>ProtocolApplieds</h3><table class="grid"><tr><td style="display: none">-</td><td><b>TargetDisease</b></td><td><b>DoseNumber[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 40468003}">Viral hepatitis, type A (disorder)</span></td><td>1</td></tr></table></div>
</text>
<extension
url="http://fhir.ch/ig/ch-core/StructureDefinition/ch-ext-author">
<valueReference>🔗
<reference value="Patient/TC-patient"/>
</valueReference>
</extension>
<extension
url="http://fhir.ch/ig/ch-vacd/StructureDefinition/ch-vacd-ext-immunization-medication-reference">
<valueReference>🔗
<reference value="Medication/TC-IMMUN-MEDIC-HAVRIX1440"/>
</valueReference>
</extension>
<identifier>
<system value="urn:oid:2.16.756.5.30.1.402.1.3.1.1.1"/>
<value value="94bdf3b1-0c04-42d3-9901-7e68f124f5ff"/>
</identifier>
<status value="completed"/>
<vaccineCode>
<coding>
<system
value="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-cs"/>
<code value="558"/>
<display value="Havrix 1440"/>
</coding>
</vaccineCode>
<patient>🔗
<reference value="Patient/TC-patient"/>
</patient>
<occurrenceDateTime value="2021-05-27"/>
<recorded value="2021-05-27T00:00:00.390+02:00"/>
<lotNumber value="AHAVB946A"/>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20035000"/>
<display value="Intramuscular use"/>
</coding>
</route>
<performer>
<actor>🔗
<reference value="PractitionerRole/TC-HCP1-ORG1-ROLE-performer"/>
</actor>
</performer>
<note>
<authorReference>🔗
<reference value="Practitioner/TC-HCP1-C1"/>
</authorReference>
<time value="2021-06-02"/>
<text
value="Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen."/>
</note>
<protocolApplied>
<targetDisease>
<coding>
<system value="http://snomed.info/sct"/>
<code value="40468003"/>
<display value="Viral hepatitis, type A (disorder)"/>
</coding>
</targetDisease>
<doseNumberPositiveInt value="1"/>
</protocolApplied>
</Immunization>